Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 노성원 | - |
dc.date.accessioned | 2018-03-21T07:59:48Z | - |
dc.date.available | 2018-03-21T07:59:48Z | - |
dc.date.issued | 2012-09 | - |
dc.identifier.citation | 대한조현병학회지(Korean Journal of Schizophrenia Research), 2012, 15(2), P.99-105, 7P. | en_US |
dc.identifier.issn | 2287-6995 | - |
dc.identifier.uri | https://synapse.koreamed.org/DOIx.php?id=10.16946/kjsr.2012.15.2.99 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.11754/50173 | - |
dc.description.abstract | Objectives : This study aimed to compare psychomotor performance related with automobile driving in patients with schizophrenia under the treatment of a typical antipsychotic agent, haloperidol, or an atypical antipsychotic agent, aripiprazole. Methods : We evaluated driving ability of schizophrenia patients by using the cognitive perceptual assessment for driving (CPAD). Twelve patients receiving haloperidol monotherapy and 18 taking aripiprazole monotherapy participated in this study and the results of CPAD were compared with each other. Results : Of 30 participants, 15 (50%) of the patients passed the CPAD to be regarded as competent to drive, 3 (10%) of the patients failed the CPAD considered to be severely impaired. Controlling for sex, age, education, duration of illness, there were no significant differences in the CPAD results between two treatment groups. We observed a trend that patients who received aripiprazole showed a higher total score of the CPAD than haloperidol-treated patients (55.2±4.9 vs. 45.7±8.4, p=0.080). Conclusion : There were no significant differences in the psychomotor performance relevant to driving ability between haloperidol and aripiprazole groups. But our results suggest that aripiprazole might have the neurocognitive advantage over haloperidol. Future study with a large sample size and diverse antipsychotics is warranted. | en_US |
dc.description.sponsorship | 이 논문은 국립서울병원의 재원으로 국립정신보건연구센터의 지원을 받아 수행된 연구이며, 운전능력 평가검사의 시행에 도움을 준 박은경, 신영애 연구간호사의 노고에 깊이 감사 드립니다.This study was supported by a grant from National Center for Mental Health Research and Education, Seoul National Hospital, Ministry of Health and Welfare, Korea. | en_US |
dc.language.iso | ko_KR | en_US |
dc.publisher | 대한조현병학회 | en_US |
dc.subject | 조현병 | en_US |
dc.subject | 할로페리돌 | en_US |
dc.subject | 아리피프라졸 | en_US |
dc.subject | 운전 | en_US |
dc.subject | 정신운동수행 | en_US |
dc.subject | Schizophrenia | en_US |
dc.subject | Haloperidol | en_US |
dc.subject | Aripiprazole | en_US |
dc.subject | Driving | en_US |
dc.subject | Psychomotor performance | en_US |
dc.title | 할로페리돌과 아리피프라졸을 복용하는 조현병 환자에서의 운전능력 관련 정신운동수행 | en_US |
dc.title.alternative | Psychomotor Performance Relevant to Driving Ability in Patients with Schizophrenia Treated with Haloperidol and Aripiprazole | en_US |
dc.type | Article | en_US |
dc.relation.journal | 대한조현병학회지 | - |
dc.contributor.googleauthor | 한지현 | - |
dc.contributor.googleauthor | 박세진 | - |
dc.contributor.googleauthor | 이종일 | - |
dc.contributor.googleauthor | 장안기 | - |
dc.contributor.googleauthor | 강시현 | - |
dc.contributor.googleauthor | 소민아 | - |
dc.contributor.googleauthor | 이경진 | - |
dc.contributor.googleauthor | 고은상 | - |
dc.contributor.googleauthor | 노성원 | - |
dc.contributor.googleauthor | Han, Ji Hyun | - |
dc.contributor.googleauthor | Park, Se Jin | - |
dc.contributor.googleauthor | Lee, Jong Il | - |
dc.contributor.googleauthor | Chang, An Kee | - |
dc.contributor.googleauthor | Kang, Shi Hyun | - |
dc.contributor.googleauthor | Soh, Minah | - |
dc.contributor.googleauthor | Lee, Kyung Jin | - |
dc.contributor.googleauthor | Koh, Eun Sang | - |
dc.contributor.googleauthor | Roh, Sungwon | - |
dc.relation.code | 2012255127 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | swroh | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.